Oncology & Hematology Coding Alert

Show Proof to Get Endoscopies Paid Separately from E/M Visits

Oncology and radiation oncology practices can gain additional deserved reimbursement when certain minor surgical procedures are performed on the same day as E/M services. Many coders erroneously believe certain minor surgical procedures are included in the E/M service. To code for both an E/M service and the separate procedure, oncology and radiation oncology practices should be sure they have documented both the medical necessity (the proper diagnosis code) and the separate and distinct nature of the E/M service and the surgical procedure, says Jim Hugh, senior vice president for AMAC, a coding consulting firm in Atlanta.

Services specific to radiation oncologists that can be separately reimbursed in this instance are:

  • 31575 Laryngoscopy, flexible fiberoptic; diagnostic
  • 45330 Sigmoidoscopy, flexible; diagnostic, with or without collection of specimen(s) by brushing or washing.
  • 92511 Nasopharyngoscopy with endoscope.
  • "Some practices routinely perform these procedures on patients who come in with throat cancer [149.0], rectal cancer [154.1] or colon cancer [153.0-153.9], but they forget that they should code these procedures separately," says Cindy Parman, CPC, CPC-H, principal and co-founder of Coding Strategies, a coding consulting firm in Dallas, Ga. Failing to separate these procedures when appropriate translates to about $80 to $130 in lost revenue per instance.

    When both the patient visit and the procedure are separately documented and reported, modifier -25 (Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service) should be appended to the E/M code (e.g., 99214-25, level-four established patient office visit) to show payers that the patient evaluation was separate and distinct from the surgical procedure. This is the case even though the surgical procedure will have E/M-type services included in the surgical procedure code. By using modifier -25, practices are telling payers that the E/M service was not a part of the preoperative or postoperative care associated with the surgical procedure.

    In general, Parman says, getting paid for both E/M services and these surgical procedures is a matter of course as long as modifier -25 is appended to the E/M visit and the documentation is in order. The key to documentation is the inclusion of a separate procedure note or a separate paragraph in the patient record detailing the procedure, techniques and findings. A procedure note should be a practice-specific document that is completed by the nurse or physician describing a procedure and its result. It should include an area where the physician signs and dates it.

    Aside from modifier -25 and documentation, oncology and radiation oncology practices should follow the rules that apply for each procedure as well, Hugh adds.

    Proving Medical Necessity for 31575

    Laryngoscopy (31575) is a method of direct visualization of the larynx by inserting a laryngoscope through the mouth and hypopharynx. To prove medical necessity, oncology practices should report diagnosis codes related to neoplasms in the throat (e.g., 161.x, Malignant neoplasm of larynx). Without codes such as 161.0 (Glottis), payers will consider the use of a laryngoscope to be a screening exam, rather than for diagnostic purposes.

    Also, if a biopsy, removal of a foreign body, or removal of a lesion is performed with 31575, you should report 31576 ( with biopsy), 31577 ( with removal of foreign body), or 31578 ( with removal of lesion).

    Proving Medical Necessity for 92511

    Nasal endoscopy (92511) is usually performed when symptoms specific to the upper airway need examination, particularly when a nasal speculum examination does not provide a satisfactory diagnosis or when the response to medical management is poor, such as when a patient's condition is not improving or is worsening. Most Medicare carriers consider a nasopharyngoscopy with endoscope medically necessary when performed to evaluate a patient with:

    1. suspected adenoid hypertrophy (474.12)
    2. recurrent serous otitis media (381.01)
    3. chronic serous and/or suppurative otitis media (382.00)
    4. suspected eustachian tube dysfunction (381.81)
    5. a neck mass of unknown etiology (784.2)
    6. nasopharyngeal signs/symptoms in which a physical examination including a nasal speculum exam failed to determine the etiology. These include such symptoms as recurrent epistaxis, throat pain, ear pain/fullness, anosmia (loss of smell), hyposnia (defect in sense of smell), anterior facial pain, nasal crusting, rhinorrhea (thin, watery discharge from the nose), etc.
    7. known neoplastic disease of the upper airway 8. acute (462) or chronic pharyngitis (472.1).

    Proving Medical Necessity for 45330

    Lower gastrointestinal endoscopy (45330) is a technique that involves a special instrument that is inserted into the body rectally, permitting visual inspection, sampling and treatment for problems of the lower gastrointestinal tract. Colonoscopic examination of the lower gastrointestinal tract is indicated and covered for the following conditions:

  • Evaluation of an abnormality on barium enema that is likely to be clinically significant, such as filling defects and other mucosal alterations
  • Discovery and excision of colonic polyps
  • Evaluation of diarrhea thought to be of an organic cause
  • Evaluation of unexplained gastrointestinal bleeding, occult or overt
  • Unexplained documented iron-deficiency anemia
  • Surveillance for colonic neoplasms
  • Examination to clear entire colon of neoplastic polyps in a patient with treatable cancer or neoplastic polyp
  • In general, follow-up examination in one year and at two- to five-year intervals after removal of neoplastic polyp or polyps. Larger polyps or multiple polyps may need to be followed more frequently
  • Follow-up examination on a yearly basis for five years following a colonic resection for colon cancer; thereafter every three to five years
  • Patients with chronic ulcerative colitis; colonoscopy every one to two years with multiple biopsies for detection of cancer and dysplasia
  • Chronic inflammatory bowel disease of the colon if more precise diagnosis or assessment of the extent of activity of disease will influence immediate management
  • Follow-up of a previously observed lesion of the colon that is of uncertain significance
  • Diagnosis and control of hemorrhage
  • Dilation of structures
  • Laser treatment of certain neoplasms.

    Additional indications may include:

  • Unexplained rectal or abdominal pain
  • Certain cases of acute diarrhea
  • Significant documented changes in bowel habits.
  • Separate payment for these procedures applies to new and established patient visits, Parman says.

    Note: Coders should check with individual carriers and get all these policies in writing.